Xavier Ayrignac

37PUBLICATIONS
207CO-AUTHORS
Gene and molecular therapyMedical infection agents (incl. prions)Neurology and neuromuscular diseasesMedical microbiology not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Oct 23, 2026
DELPHI expert consensus-derived factors influencing the early use of monoclonal high-efficacy therapies in treatment-naïve patients with relapsing-remitting multiple sclerosis.

|Sep 26, 2026
Serum GFAP and Age Accurately Distinguish AQP4-IgG Positive and Double Seronegative NMOSD From MOGAD After a Recent Attack.

|Jun 15, 2026
Blood Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Candidate Biomarkers in CSF1R-Related Disorder.

|May 22, 2026
French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024.

|May 07, 2026
Intracranial and Peripheral Inflammatory Biomarkers Predict Futile Recanalization After Endovascular Treatment.

|May 06, 2026
Kappa free light chain index or oligoclonal bands testing in clinical practice for multiple sclerosis diagnosis: An algorithm comparative study.

Pageof 7

Frequent Collaborators

13 joint publications

Elisabeth Maillart

10 joint publications

Romain Marignier

10 joint publications

Jonathan Ciron

10 joint publications

Bertrand Audoin